drugset / Trial / NCT04283240

Sildenafil in Acute Pulmonary Embolism

NCT04283240

Phase 0 Completed 20 enrolled University of Aarhus
RandomizedParallel-groupQuadruple-blindBasic science

Summary

To investigate if acute pulmonary vasodilation by sildenafil improves right ventricular function in patients with acute intermediate-high risk pulmonary embolism (PE).

Timeline

Start
2015-03-01
Primary completion
2017-09-10
Completion
2018-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 50 mg Oral

Indications